Riskpilot← Back to searchSign inGet full accessHOLMVIK AS
ASActiveOrg 824681872Østensenveien 9, 8009 BodøGeneral medical practice activities · NACE 8621Est. 20203 employees
Revenue 2024
NOK 3,6M
-13% vs 2023
EBITDA margin
10.2%
-54% vs 2023
Equity ratio
70.7%
Financial strength
Net profit 2024
NOK -88K
-115% vs 2023
| Revenue | NOK 3,6M | -13% |
| EBITDA | NOK 368K | -54% |
| Net profit | NOK -88K | -115% |
| Total assets | NOK 1,6M | -20% |
| Equity | NOK 1,1M | -20% |
| Employees | 3 | — |
Legal name
HOLMVIK AS
Org number
824681872
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
28. februar 2020
Share capital
NOK 30 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Allmenn legepraksis og alt som naturlig faller inn under dette, samt guidet dykking og opplæring.
Address
Østensenveien 9, 8009 Bodø
Phone
+4776134796
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 631 | 3 953 | 4 155 | 4 145 | 3 610 |
| Staff expenses | −2 085 | −1 943 | −2 285 | −2 330 | −2 200 |
| EBITDA | 427 | 833 | 695 | 795 | 368 |
| Depreciation & amort. | −7 | −14 | −21 | −20 | −0 |
| EBIT | 419 | 818 | 674 | 775 | 368 |
| Net financials | 0 | −0 | −124 | −0 | −375 |
| Profit before tax | 419 | 818 | 550 | 775 | −7 |
| Tax | 91 | 180 | 148 | 170 | 81 |
| Net profit | 328 | 638 | 401 | 604 | −88 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 872 | 1 181 | 1 522 | 1 990 | 1 587 |
| Equity | 233 | 669 | 806 | 1 411 | 1 122 |
| Long-term debt | 1 | 1 | 0 | 0 | 0 |
| Short-term debt | 639 | 511 | 715 | 579 | 464 |
| Total debt | 640 | 512 | 715 | 579 | 464 |
EBITDA margin
10.2%
This company
15.8%
Market median
-35% vs market
20202024
Equity ratio
70.7%
This company
38.2%
Market median
+85% vs market
20202024
Return on equity
-7.9%
This company
18.4%
Market median
-143% vs market
20202024
Net profit margin
-2.4%
This company
8.1%
Market median
-130% vs market
20202024
Asset turnover
2.28×
This company
1.12×
Market median
+104% vs market
20202024
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LC Chief Executive Officer | Chief Executive Officer | 2020 |
LC Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HOLMVIK AS 
Ahead Of Health AsBoard members of HOLMVIK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Cecilia Holmvik | Chief Executive Officer | 0 companies |
| Lena Cecilia Sivertsen | Chief Executive Officer | 0 companies |
| Stian Holmvik | Chairman | 0 companies |